← Leaderboards
Chuo Chen
Ut Southwestern Medical Center
$9,073,859
Attributed
$11,797,321
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,797,321 · 9
By mechanism
R01$10,913,888 · 5
R21$881,666 · 2
P41$1,767 · 2
Top collaborators
- Jing Huang5 shared
- Xiaochen Bai3 shared
- Xuewu Zhang3 shared
- James F Amatruda2 shared
- Lawrence Lum2 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Russell Alfred Debose-Boyd$14,724,021
- Jay D Horton$17,439,528
- William T Dauer$16,076,801
- Helen H. Hobbs$30,094,310
- Mike Henne$5,287,559
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeProgramsPharmaceutical PreparationsPropertyMolecularFutureBaseProteinsCellsInterestPathway InteractionsDesignComplexModificationStructureResponseCancer TherapyAnalogNovel TherapeuticsBiologicalIn VivoBiological FactorsMalignant NeoplasmsDrug Development
Grant awards (33)
Novel regulatory mechanisms and agonists of STING$680,598
R01 · FY2025 · CA
Therapeutic targeting of Wnt signaling in cancer$648,718
R01 · FY2025 · CA · contact PI
Novel regulatory mechanisms and agonists of STING$646,571
R01 · FY2024 · CA
Therapeutic targeting of Wnt signaling in cancer$616,283
R01 · FY2024 · CA · contact PI
Novel regulatory mechanisms and agonists of STING$680,598
R01 · FY2023 · CA
Therapeutic targeting of Wnt signaling in cancer$648,718
R01 · FY2023 · CA · contact PI
Explore the therapeutic potential of small-molecule immune modulators$380,217
R01 · FY2023 · CA · contact PI
Explore the therapeutic potential of small-molecule immune modulators$380,217
R01 · FY2022 · CA · contact PI
Explore the therapeutic potential of small-molecule immune modulators$387,977
R01 · FY2021 · CA · contact PI
A New Chemical Technology for Biological Studies and Therapeutic Applications$245,750
R21 · FY2021 · GM · contact PI
Explore the therapeutic potential of small-molecule immune modulators$387,977
R01 · FY2020 · CA · contact PI
A New Chemical Technology for Biological Studies and Therapeutic Applications$204,166
R21 · FY2020 · GM · contact PI
Explore the therapeutic potential of small-molecule immune modulators$387,977
R01 · FY2019 · CA · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$299,820
R01 · FY2016 · GM · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$89,754
R01 · FY2016 · GM · contact PI
Identifying molecular targets and biological signatures of CAM natural products$431,985
R01 · FY2015 · AT · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$299,820
R01 · FY2015 · GM · contact PI
Identifying molecular targets and biological signatures of CAM natural products$431,984
R01 · FY2014 · AT · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$299,820
R01 · FY2014 · GM · contact PI
Identifying molecular targets and biological signatures of CAM natural products$431,984
R01 · FY2013 · AT · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$299,820
R01 · FY2013 · GM · contact PI
Identifying molecular targets and biological signatures of CAM natural products$445,346
R01 · FY2012 · AT · contact PI
Identifying molecular targets and biological signatures of CAM natural products$452,935
R01 · FY2011 · AT · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$263,127
R01 · FY2011 · GM · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$265,785
R01 · FY2010 · GM · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$231,447
R01 · FY2010 · GM · contact PI
Chemical disruption of the Hh and Wnt pathways in vertebrate development$196,250
R21 · FY2010 · HD
Asymmetric Synthesis of Biologically Active Marine Natural Products$268,470
R01 · FY2009 · GM · contact PI
Chemical disruption of the Hh and Wnt pathways in vertebrate development$235,500
R21 · FY2009 · HD
Asymmetric Synthesis of Biologically Active Marine Natural Products$268,470
R01 · FY2008 · GM · contact PI
NATURAL PRODUCT SYNTHESIS AND CHEMICAL BIOLOGY OF NOVEL SKELETAL STRUCTURES$637
P41 · FY2008 · RR · contact PI
Asymmetric Synthesis of Biologically Active Marine Natural Products$287,470
R01 · FY2007 · GM · contact PI
NATURAL PRODUCT SYNTHESIS AND CHEMICAL BIOLOGY OF NOVEL SKELETAL STRUCTURES$1,130
P41 · FY2007 · RR · contact PI